Wolfe Research analyst Justin Lake downgraded Oak Street Health (OSH) to Peer Perform from Outperform without a price target citing the pending takeover by CVS Health (CVS). The firm expects the deal to close in 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OSH:
- Oak Street Health downgraded to Market Perform from Outperform at TD Cowen
- Oak Street Health reports FY22 revenue $2.16B, consensus $2.15B
- Oak Street Health downgraded to Neutral from Overweight at JPMorgan
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein
- Oak Street Health downgraded to Market Perform from Outperform at Raymond James